Who are NATURECELL's main competitors?

Named competitors: CHA Biotech (085660.KS), Mesoblast (MSB.AX). The cockpit's measured peer set (industry) also includes Shenzhen Cereals (000019.SZ), Lassonde Industries (LAS-A.TO), Princes (PRN.L), A.G. BARR p.l.c (BAG.L), Fevertree Drinks (FEVR.L), LotteChilsung (005300.KS).

Is NATURECELL expensive compared with its peers?

On ev / sales it trades at 68.7× against a peer median of 1.6×, most expensive of 21 in its peer set.

How has NATURECELL stock performed?

Over six months to 6 Nov 2026 the shares returned +14.4% against -2.0% for the median peer; over one year -13.3%.

← CockpitCompetitor Analysis › 007390.KS NATURECELL Co., Ltd.Open in the cockpit ↗

NATURECELL Co., Ltd.007390.KSCompetitor analysis, valuation and peers

South Korea · KRW·Consumer Staples›Beverages: Non-Alcoholic

Korean biotech developing autologous stem-cell therapies, including a knee-osteoarthritis treatment, made from patients' own fat tissue.

Momentum leader 85

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$1.04B

US dollars, full cap

Free float

82%

of shares outstanding

$/day

$3.64M

20-day average traded

Fwd P/E

n/m

no positive forecast

ROIC−WACC

-12.5 pp

WACC 8.1%

Hurdle

n/a

no reverse DCF

Close · KRW₩21,900

1D-0.5%

1W+0.5%

1M-11.3%

3M-0.2%

6M+14.4%

YTD+0.5%

1Y-13.3%

ATR %5.7%

52w lowhigh40.7% off high

What NATURECELL does

Korean biotech developing autologous stem-cell therapies, including a knee-osteoarthritis treatment, made from patients' own fat tissue.

Products and services

JOINTSTEM (knee osteoarthritis stem-cell therapy)
Stem-cell banking services

Customers

Orthopedic clinics/hospitals (licensees)

Where it sits in the supply chain

Biotechnology
Autologous stem-cell therapeutics
Cell-therapy clinical development

What could go right

Regulatory approval in new markets

What could go wrong

Clinical/regulatory setback risk
Past governance/promotion controversies

Moat: narrow (IP / patents, regulatory licence). Patented autologous stem-cell process, though facing efficacy/regulatory skepticism.

Headquarters: Seoul, South Korea · Founded: 2002 · Employees: 83

Named competitors

CHA Biotech 085660.KS
Mesoblast MSB.AX

NATURECELL at a glance

Size NATURECELL (007390.KS) is a South Korea Consumer Staples company (Beverages: Non-Alcoholic) with a market value of $1.04B, the 228th largest of 495 South Korea companies the cockpit tracks. Shares closed at ₩21,900 on 6 Nov 2026.

Performance Over six months the shares gained 14.4%, against -2.0% for the median peer and -24.5% for the South Korea market (cap-weighted) — 4th highest of 20 in its peer set.

Growth Revenue fell 14.7% over the last twelve months (peer median +2.7%); the operating margin is -17.9% (peer median 8.2%).

Valuation It trades at 68.7× enterprise value to sales against a peer median of 1.6× (most expensive of 21).

Capital Return on invested capital runs 12.5 points below its cost of capital (8.1% WACC).

Relative performance

Six months, rebased to 100: NATURECELL against the median of its 20 peers (local-currency closes).

NATURECELL financials

Reported figures in KRW; fiscal year ends 2025-12-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	₩20.5B	₩20.7B	₩32.3B	₩19.4B	₩21.3B
Revenue growth	—	-36%	+67%	-9%	—
Gross profit	₩8.66B	₩8.15B	₩15.5B	₩7.05B	₩8.41B
EBITDA	-₩1.73B	-₩1.82B	₩2.48B	-₩8.82B	-₩8.10B
Net income	-₩2.71B	-₩2.84B	₩1.23B	-₩11.7B	-₩10.3B
Free cash flow	-₩22.5B	-₩16.4B	-₩1.59B	-₩8.25B	-₩18.7B
Capital expenditure	₩15.7B	₩16.6B	₩3.12B	₩6.12B	₩3.80B
Total debt	₩19.8B	₩7.80B	₩1.78B	₩2.31B	₩25.5B

Quarterly statements and history in the cockpit →

NATURECELL competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

Up and to the right = strong over both horizons. NATURECELL is the large dot.

Fundamentals: revenue growth against valuation

Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. NATURECELL is the large dot.

NATURECELL competitors and peer comparison

Head to head with its named competitors (007390.KS vs 085660.KS vs MSB.AX)
Company	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g
NATURECELL 007390.KS	$1.04B	+14%	-15%	-18%	68.7×	n/a
CHA Biotech 085660.KS	$499M	-57%	+14%	-6%	1.3×	n/a
Mesoblast MSB.AX	$1.83B	0%	+556%	-43%	15.2×	n/a

How NATURECELL compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

NATURECELL against its 20 peers (data as of 6 Nov 2026)
Measure	007390.KS	Peer median	Rank in peer set
1-month return	-11.3%	+0.8%	3rd lowest of 21
6-month return	+14.4%	-2.0%	4th highest of 20
Distance from 52-week high	-40.7%	-21.8%	3rd lowest of 21
Revenue growth (TTM)	-14.7%	+2.7%	2nd lowest of 20
Operating margin	-17.9%	8.2%	lowest of 20
EV / Sales	68.7×	1.6×	most expensive of 21
ROIC minus cost of capital	-12.5 pp	+0.6 pp	2nd lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g	Delivered g
NATURECELL 007390.KS	South Korea	$1.04B	+14%	-15%	-18%	68.7×	n/a	n/a
Shenzhen Cereals 000019.SZ	China	$1.04B	-20%	+1%	6%	1.6×	4.6%	-14.3%
Lassonde Industries LAS-A.TO	Canada	$1.14B	+4%	+2%	9%	0.7×	-13.2%	+8.2%
Princes PRN.L	United Kingdom	$1.21B	-3%	+30%	4%	0.3×	-7.1%	+9.3%
A.G. BARR p.l.c BAG.L	United Kingdom	$887M	-2%	+7%	15%	1.6×	n/a	n/a
Fevertree Drinks FEVR.L	United Kingdom	$1.36B	+18%	+2%	9%	2.8×	27.9%	+5.2%
LotteChilsung 005300.KS	South Korea	$791M	-9%	+1%	5%	0.7×	-2.0%	+12.0%
China Foods 0506.HK	Hong Kong	$1.43B	+8%	+4%	8%	0.4×	-17.0%	+4.3%
DyDo 2590.T	Japan	$624M	+21%	+3%	4%	0.4×	n/a	n/a
Nanfang Black Sesame 000716.SZ	China	$590M	+2%	+5%	2%	2.0×	28.5%	-10.1%
Nichols NICL.L	United Kingdom	$539M	+18%	+3%	18%	1.9×	0.2%	+8.1%
Zhe Jiang Li Zi Yuan Food 605337.SS	China	$526M	-17%	-4%	12%	3.0×	n/a	n/a
Premium Water 2588.T	Japan	$483M	+4%	+4%	16%	1.5×	-11.0%	+7.4%
China Resources Beverage (Holdings) 2460.HK	Hong Kong	$2.27B	-14%	-19%	6%	1.0×	n/a	n/a
SDIC Zhonglu Fruit Juice 600962.SS	China	$2.62B	-1%	+100%	n/a	3.8×	n/a	n/a
Lifedrink 2585.T	Japan	$410M	-12%	+21%	10%	1.6×	n/a	n/a
Hey-Song 1234.TW	Taiwan	$389M	-9%	-8%	5%	1.4×	10.4%	+0.7%
Suja Life SUJA	United States	$382M	n/a	n/a	-6%	1.9×	n/a	n/a
5100 Xizang Glacier 1115.HK	Hong Kong	$349M	-10%	+67%	21%	7.7×	n/a	n/a
Hokkaido Coca-Cola Bottling 2573.T	Japan	$339M	-6%	+4%	4%	0.8×	7.6%	+2.8%
National Beverage FIZZ	United States	$3.48B	+6%	-2%	18%	2.9×	3.4%	+1.9%

Questions

Who are NATURECELL's main competitors?: Named competitors: CHA Biotech (085660.KS), Mesoblast (MSB.AX). The cockpit's measured peer set (industry) also includes Shenzhen Cereals (000019.SZ), Lassonde Industries (LAS-A.TO), Princes (PRN.L), A.G. BARR p.l.c (BAG.L), Fevertree Drinks (FEVR.L), LotteChilsung (005300.KS).
Is NATURECELL expensive compared with its peers?: On ev / sales it trades at 68.7× against a peer median of 1.6×, most expensive of 21 in its peer set.
How has NATURECELL stock performed?: Over six months to 6 Nov 2026 the shares returned +14.4% against -2.0% for the median peer; over one year -13.3%.